<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2022.1065386</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Whole-genome sequencing, annotation, and biological characterization of a novel Siphoviridae phage against multi-drug resistant <italic>Propionibacterium acne</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liao</surname>
<given-names>Danxi</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2043587/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jian</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Ruolan</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2119218/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Kui</given-names>
</name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yuanyuan</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2119177/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shao</surname>
<given-names>Yuming</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Xi</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Yiming</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="c002" ref-type="corresp"><sup>&#x002A;</sup></xref>
<xref rid="fn0001" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1594258/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Zichen</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<xref rid="fn0001" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1833370/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Plastic and Cosmetic Surgery, Xinqiao Hospital, The Second Affiliated Hospital, Army Medical University (The Third Military Medical University)</institution>, <addr-line>Chongqing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Clinical Laboratory, Xinqiao Hospital, The Second Affiliated Hospital, Army Medical University (The Third Military Medical University)</institution>, <addr-line>Chongqing</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Cadet Brigade 4, College of Basic Medicine, Army Medical University (The Third Military Medical University)</institution>, <addr-line>Chongqing</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Microbiology, College of Basic Medicine, Army Medical University (The Third Military Medical University)</institution>, <addr-line>Chongqing</addr-line>, <country>China</country></aff>
<author-notes>
<fn id="fn0001" fn-type="equal"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
<fn id="fn0002" fn-type="edited-by"><p>Edited by: Min Jin, State Oceanic Administration, China</p></fn>
<fn id="fn0003" fn-type="edited-by"><p>Reviewed by: Xiyang Dong, Third Institute of Oceanography of the Ministry of Natural Resources, China; Tianliang He, Fujian Agriculture and Forestry University, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Zichen Yang <email>zichen_yang@yahoo.com</email></corresp>
<corresp id="c002">Yiming Zhang, <email>zhangyiming@tmmu.edu.cn</email></corresp>
<fn id="fn0004" fn-type="other"><p>This article was submitted to Phage Biology, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1065386</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>11</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Liao, Zhang, Liu, Chen, Liu, Shao, Shi, Zhang and Yang.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Liao, Zhang, Liu, Chen, Liu, Shao, Shi, Zhang and Yang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Antibiotics-resistant <italic>Propionibacterium acne</italic> (<italic>P. acne</italic>) causes severe acne vulgaris, serious public health, and psychological threat. A new lytic bacteriophage (phage), &#x03C6;PaP11-13, infecting <italic>P. acne,</italic> was isolated from the sewage management center of Xinqiao Hospital. It can form transparent plaque with diameters of 1.0&#x2009;~&#x2009;5.0&#x2009;mm on the double-layer agar plate, indicating a robust lytic ability against its host. Transmission electron microscopy (TEM) showed that &#x03C6;PaP11-13 belonged to the Siphoviridae family (head diameter 60&#x2009;&#x00B1;&#x2009;4.5&#x2009;nm, tail length 170&#x2009;&#x00B1;&#x2009;6.4&#x2009;nm, tail width 14&#x2009;&#x00B1;&#x2009;2.4&#x2009;nm). The one-step growth curve showed the incubation period was 5&#x2009;h, and the burst size was 26 PFU (plaque-forming unit)/cell. Moreover, it exhibited tolerance over a broad range of pH and temperature ranges but was utterly inactivated by ultraviolet (UV) irradiation for 1&#x2009;h. The whole-genome sequencing results revealed &#x03C6;PaP11-13 had a linear dsDNA with 29,648&#x2009;bp length. The G/C content was 54.08%. Non-coding RNA genes and virulence factors were not found. Forty five open reading frames (ORFs) were identified after online annotation. This study reports a novel <italic>P. acne</italic> phage &#x03C6;PaP11-13, which has a robust lytic ability, no virulence factors, and good stability. The characterization and genomic analysis of &#x03C6;PaP11-13 will develop our understanding of phage biology and diversity and provide a potential arsenal for controlling antibiotics-resistant <italic>P. acne</italic>-induced severe acne vulgaris.</p>
</abstract>
<kwd-group>
<kwd><italic>Propionibacterium acne</italic>
</kwd>
<kwd>bacteriophage</kwd>
<kwd>severe acne vulgaris</kwd>
<kwd>antibiotics-resistant</kwd>
<kwd>phage therapy</kwd>
</kwd-group>
<counts>
<fig-count count="9"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="47"/>
<page-count count="13"/>
<word-count count="7188"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>Introduction</title>
<p>Acne vulgaris is the eighth most prevalent disease worldwide, and 85% of the patients are young people aged 12&#x2013;24 (<xref ref-type="bibr" rid="ref40">Tan and Bhate, 2015</xref>; <xref ref-type="bibr" rid="ref28">Lynn et al., 2016</xref>). Severe acne vulgaris mainly occurs in the frontal region, chest, back, and shoulder, where people always experience horrible feelings (<xref ref-type="bibr" rid="ref6">Choi et al., 2012</xref>). Although acne vulgaris is not a fatal disease, the disfiguring and recurrent consequence brings psychosocial problems, particularly in severe cases (<xref ref-type="bibr" rid="ref38">Silverberg and Silverberg, 2014</xref>). Not to mention that improper treatment aggravates lesions and irritates immunological reactions (<xref ref-type="bibr" rid="ref26">Lavers and Courtenay, 2011</xref>).</p>
<p><italic>Propionibacterium acnes</italic> (<italic>P. acnes</italic>), also known as <italic>Cutibacterium acnes,</italic> infection or imbalance of this commensal bacterium is one of the critical causes of the aggravation of acne vulgaris (<xref ref-type="bibr" rid="ref10">Dr&#x00E9;no et al., 2018</xref>). Moreover, severe acne induced by antibiotic-resistant <italic>P.acne</italic> infection is more difficult to treat (<xref ref-type="bibr" rid="ref31">Nakase et al., 2017</xref>). According to <italic>Treatment Guidelines from the AAD</italic>, the first-line treatment for severe acne vulgaris caused by <italic>P. acne</italic> includes oral isotretinoin and tetracyclines (<xref ref-type="bibr" rid="ref19">Hauk, 2017</xref>). However, tetracycline requires a long period of application (often &#x003E;&#x2009;6&#x2009;months) (<xref ref-type="bibr" rid="ref14">Fox et al., 2016</xref>), which inevitably arouses side effects on the body (<xref ref-type="bibr" rid="ref32">Nakase et al., 2018</xref>). Abundant studies have shown that tetracycline resistance in <italic>P. acne</italic> is becoming increasingly evident (<xref ref-type="bibr" rid="ref31">Nakase et al., 2017</xref>). Moreover, the long therapy duration increases the likelihood of overgrowth of antibiotic resistance in <italic>P. acne</italic> (<xref ref-type="bibr" rid="ref34">Oprica et al., 2004</xref>). Mendoza even reported tetracycline-resistant <italic>P. acne</italic> isolated from the faces of patients who had never taken tetracycline (<xref ref-type="bibr" rid="ref30">Mendoza et al., 2013</xref>). Thus, there is an urgent need for alternative therapies against antibiotics-resistant <italic>P. acne</italic>-induced severe acne vulgaris.</p>
<p>Phages are viruses that infect, parasitize, and lyse bacteria with precision and efficiency (<xref ref-type="bibr" rid="ref18">Gordillo Altamirano and Barr, 2019</xref>). Since the 1920s, phages with high bactericidal activity have been used to treat human bacterial infectious diseases (<xref ref-type="bibr" rid="ref21">Kortright et al., 2019</xref>). In recent years, antimicrobial resistance (AMR) has become a growing problem, and this &#x201C;phage therapy&#x201D; has received renewed attention (<xref ref-type="bibr" rid="ref21">Kortright et al., 2019</xref>). <italic>P. acne</italic> phage has a long history. The <italic>P. acne</italic> phage was first identified in 1964 (<xref ref-type="bibr" rid="ref5">Brzin, 1964</xref>). Subsequently, <xref ref-type="bibr" rid="ref47">Zierdt et al. (1968)</xref> conducted in-depth studies and found it had similar morphology, broad host range, and good stability (<xref ref-type="bibr" rid="ref46">Zierdt, 1974</xref>; <xref ref-type="bibr" rid="ref11">Farrar et al., 2007</xref>). Phages can treat bacterial infections regardless of antibiotics-resistance (<xref ref-type="bibr" rid="ref45">Yin et al., 2017</xref>; <xref ref-type="bibr" rid="ref42">Yang et al., 2019a</xref>). There were reports on <italic>P. acne</italic> phage effectively treating multi-drug-resistant <italic>P. acne</italic>-induced acne vulgaris in animal experiments (<xref ref-type="bibr" rid="ref24">Lam et al., 2021</xref>) and clinical trials (<xref ref-type="bibr" rid="ref17">Golembo et al., 2022</xref>), indicating potential clinical values. However, phage therapy for treating severe acne vulgaris induced by antibiotic-resistant <italic>P. acne</italic> is insufficient. More research is needed on the phage genomic backgrounds and future host-phage interactions.</p>
<p>We isolated and identified a novel <italic>P. acne</italic> phage with solid lytic abilities against a clinical antibiotics-resistant <italic>P. acne</italic> strain Pacne11-13. The biological characterization and genome annotation may provide vital information for the application of antibiotics-resistant <italic>P. acne</italic>-induced severe acne vulgaris treatment and further studies.</p>
</sec>
<sec id="sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec3">
<title>Bacterial gene sequencing and antimicrobial susceptibility test</title>
<p>The clinical <italic>P. acne</italic> strain Pacne11-13 was separated from facial abscesses in patients with severe acne vulgaris, identified by VITEK 2 Compact system (BioM&#x00E9;rieux, France) (<xref ref-type="bibr" rid="ref10">Dr&#x00E9;no et al., 2018</xref>). The gene sequencing of Pacne11-13 was performed using PacBio Sequel and Illumina NovaSeq PE150 platforms. Software Diamond and the Antibiotic Resistance Genes Database (ARDB) (<xref ref-type="bibr" rid="ref27">Liu and Pop, 2009</xref>) combined the sequenced genes with the antibiotic-resistance functional annotation information to obtain the results. The antibiotics susceptibility test of Pacne11-13 (tetracycline, aminoglycosides, cephalosporins, and clindamycin) was tested using the disk diffusion method (Rosco Neo-Sensitab) (<xref ref-type="bibr" rid="ref35">Schuetz, 2014</xref>). The Pacne11-13 was grown in a BHI medium (Brain-Heart-Infusion, Oxoid, United Kingdom) and incubated at 37&#x00B0;C in a hypoxic incubator (HR900-IIB2, ESCO).</p>
</sec>
<sec id="sec4">
<title>Phage isolation and purification</title>
<p><italic>P. acne</italic> phage was screened and enriched as previously described (<xref ref-type="bibr" rid="ref20">Huang et al., 2014</xref>; <xref ref-type="bibr" rid="ref43">Yang et al., 2019b</xref>), with some alterations. Briefly, sewage water samples from the sewage management center at Xinqiao Hospital used as sources of phages were collected and then centrifuged (Ultracentrifuge AG22331, Eppendorf, German) at 10000&#x2009;&#x00D7;&#x2009;<italic>g</italic> for 15&#x2009;min at 4&#x00B0;C. The supernatant was filtered through 0.22-&#x03BC;m PES needle filters (Millipore, United States) to remove any remaining bacteria. Then <italic>P. acne</italic> was cultured to the exponential phase (OD600&#x2009;=&#x2009;0.6) and was taken 1&#x2009;ml to mix with 10&#x2009;ml sewage filter liquor. The growth curve of host bacteria is in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>. Then the mixture was added to a 100&#x2009;ml BHI liquid medium and co-cultivated for 24&#x2009;h on a hypoxic rocking platform at 37&#x00B0;C to enrich any <italic>P. acne</italic> phages in the sewage samples. The next day, this mixture was centrifuged at 10,000&#x2009;&#x00D7;&#x2009;<italic>g</italic> for 10&#x2009;min at 4&#x00B0;C, and the supernatant was passed through 0.22-&#x03BC;m PES needle filters. The phage was purified and separated by picking single-plaque with the double-layer agar method (<xref ref-type="bibr" rid="ref37">Shi et al., 2021</xref>). And the resulting isolation was stored at 4&#x00B0;C.</p>
</sec>
<sec id="sec5">
<title>Transmission electron microscopy</title>
<p>Three 3-&#x03BC;L aliquots of the high-titer phage preparations (10<sup>10</sup>&#x2009;~&#x2009;10<sup>13</sup> PFU /mL) were pipetted on carbon-coated copper grids as instructed (<xref ref-type="bibr" rid="ref37">Shi et al., 2021</xref>). After allowing the phages to adsorb for 1&#x2009;min, the grids were stained with 2% uranyl acetate (pH 4.2) for 30&#x2009;s. Then the morphology of &#x03C6;PaP11-13 was observed and photographed under TEM (Hitachi HTT700, Japan). The heads and tails of 5 individual phage particles were measured by Image-Pro Plus6.0 image analysis software (Media Cybernetics 6.0, United States) to calculate the averages and standard errors for the dimensions (<xref ref-type="bibr" rid="ref42">Yang et al., 2019a</xref>).</p>
</sec>
<sec id="sec6">
<title>The optimal MOI and optimal adsorption time</title>
<p>The multiplicity of infection (MOI) refers to the ratio of the plaque-forming unit (PFU) to the colony-forming unit (CFU). Firstly, the titer of <italic>P. acne</italic> was adjusted to 1&#x2009;&#x00D7;&#x2009;10<sup>8</sup>&#x2009;CFU/ml and &#x03C6;PaP11-13 to 1&#x2009;&#x00D7;&#x2009;10<sup>8</sup> PFU/mL. Then mixed the <italic>P. acne</italic> with the &#x03C6;PaP11-13 in proportion (10.000, 1.0000, 0.1000, 0.0100, 0.0010, and 0.0001). After 24&#x2009;h, phage titers were measured by the spot test (<xref ref-type="bibr" rid="ref36">Shi et al., 2020</xref>). The proportion with the highest phage titer was the optimal MOI.</p>
<p>The phages and bacteria were mixed at the optimal MOI tested in the above experiments. Placed it in a hypoxia incubator and incubated for 5, 10, and 15&#x2009;min. It was the optimal adsorption time when the phage titer was the lowest. Those experiments were repeated three times, and three parallel averages were taken under per-scale titers. The measurement data conformed to the normal distribution and were expressed as mean&#x2009;&#x00B1;&#x2009;standard errors.</p>
</sec>
<sec id="sec7">
<title>One&#x2013;step growth curve</title>
<p>A one-step growth curve, including incubation, lysis, and platform period, can demonstrate the phage life cycle. &#x03C6;PaP11-13 was mixed with <italic>P. acne</italic> at optimal MOI (0.0100) and adsorption at 37&#x00B0;C for optimal adsorption time (10&#x2009;min). The mixture was centrifuged at 10000&#x2009;&#x00D7;&#x2009;<italic>g</italic> for 60&#x2009;s to clear unabsorbed phages from the supernatant. Then the residue was washed twice with BHI liquid medium on ice, resuspended by 5&#x2009;ml BHI liquid medium, and cultured in a hypoxic incubator at 37&#x00B0;C. Samples were taken out at 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12&#x2009;h after injection, and the spot test measured the titer. According to previous reports, the burst size was calculated based on the one-step growth curve (<xref ref-type="bibr" rid="ref22">Kropinski, 2018</xref>). This experiment was performed in triplicate.</p>
</sec>
<sec id="sec8">
<title>Stability tests of &#x03C6;PaP11-13</title>
<p>To test the stability of &#x03C6;PaP11-13 under various conditions, we measured its titer at different temperatures, pH, UV, and Chloroform conditions, using our previously described method with some alterations (<xref ref-type="bibr" rid="ref36">Shi et al., 2020</xref>). The &#x03C6;PaP11-13 solution was incubated in a water bath at different temperatures (&#x2212;20, 4, 37, 50, 60, 70, and 80&#x00B0;C), and phage titers were measured after 1&#x2009;h. Likewise, to measure the pH stability of &#x03C6;PaP11-13, samples were incubated at different pH values (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13) at 37&#x00B0;C and samples were taken out for phage titer determination after 1&#x2009;h. Then, to measure the UV stability of the phage. The phage sample was added to a 16-well plate, and the cover was removed and placed under UV light. After 0, 5, 10, 30, and 60&#x2009;min of irradiation, the phage titers were measured. Finally, measured the stability of Chloroform. The spot test was used to measure the phage titer in the above experiments, and those experiments were repeated three times. The data were analyzed by GraphPad Prism version 9 for Windows (GraphPad Software, La Jolla, CA, United States).</p>
</sec>
<sec id="sec9">
<title>Host range</title>
<p>Spot test and double-layer agar plate were used to determine the host range of &#x03C6;PaP11-13. Sixteen strains of <italic>P. acnes</italic> isolated from facial abscesses in patients were used for the host range experiment. 300&#x2009;&#x03BC;l host bacteria with logarithmic phase (OD600&#x2009;=&#x2009;0.6) of each strain was mixed with 5&#x2009;ml semi-solid agar and then poured into the bottom agar plate. 5&#x2009;&#x03BC;l &#x03C6;PaP11-13 solution (10<sup>10</sup> PFU/ml) was dropped onto the upper agar with more than three spots per plate. After the phage suspension was adsorbed, the plate was incubated in a hypoxic incubator at 37&#x00B0;C for 24&#x2009;h.</p>
</sec>
<sec id="sec10">
<title>DNA extraction and genome sequencing</title>
<p>Phage DNA was extracted using the standard Protease-K/SDS DNA extraction method (<xref ref-type="bibr" rid="ref36">Shi et al., 2020</xref>). The nucleic acid concentration was measured using a NanoDrop spectrophotometer (ND-1000, Wilmington, DE, United States). This genome sequencing adopted the Whole Genome Shotgun (WGS) strategy to construct libraries of different insertions and utilized Next-Generation Sequencing (Dr&#x00E9;no et al.) technology based on the Illumina NovaSeq Sequencing platform. Paired-end (PE) sequencing was performed on these libraries.</p>
</sec>
<sec id="sec11">
<title>Whole genome sequence annotation and analysis</title>
<p>Phageterm (<xref ref-type="bibr" rid="ref15">Garneau et al., 2017</xref>) was used to predict the genome ends of &#x03C6;PaP11-13, and GeneMarkS (<xref ref-type="bibr" rid="ref3">Brettin et al., 2015</xref>), RAST (<xref ref-type="bibr" rid="ref2">Aziz et al., 2008</xref>), and PHASTER (<xref ref-type="bibr" rid="ref1">Arndt et al., 2016</xref>) were used as genome prediction software to predict ORFs of the assembled &#x03C6;PaP11-13 genome sequence. Then the predicted ORF was proofread using the Basic Local Alignment Search Tool (BLAST) of NCBI.<xref rid="fn0005" ref-type="fn"><sup>1</sup></xref> The annotated nucleotide sequence of the &#x03C6;PaP11-13 genome was submitted to the NCBI database under the accession number: ON557706, and the CGView Server BETA<xref rid="fn0006" ref-type="fn"><sup>2</sup></xref> (<xref ref-type="bibr" rid="ref39">Stothard et al., 2019</xref>) was used to visualize the &#x03C6;PaP11-13 genome. To analyze the evolution trend and relation of &#x03C6;PaP11-13 with other known phages, Mauve 20,150,226 was used for collinearity analysis (<xref ref-type="bibr" rid="ref7">Darling et al., 2004</xref>), and Mega-X 10. 0. 2 was used for phylogenetic tree analysis of the major terminal large subunit sequences (<xref ref-type="bibr" rid="ref23">Kumar et al., 2018</xref>).</p>
</sec>
<sec id="sec12">
<title>Identification of phage proteins</title>
<p>Liquid nitrogen was added to the phage particle, and then it was ground to powder. Then the phage particle was lysed by ultrasound, and a BCA kit measured its protein concentration. 5&#x2009;&#x03BC;l of 4&#x2009;&#x00D7;&#x2009;loading buffer and 2% SDS were added to the sample and then electrophoretic. The silver dyeing method was transferred into the chromogenic solution for about 10&#x2009;min at room temperature, and clear bands were finally visible. Then the cut protein bands were tested by LC&#x2013;MS/MS system (UPLC, EASY-nLC 1,200 system, PTM BioLab, Hangzhou) for phage major protein analysis. Then cross-checking underwent between LC&#x2013;MS/MS results and whole genome annotation.</p>
</sec>
</sec>
<sec id="sec13" sec-type="results">
<title>Results</title>
<sec id="sec14">
<title>Antimicrobial resistance genes annotation and AST analysis of clinically isolated strain Pacne11-13</title>
<p>The whole genome of Pacne11-13 underwent sequencing. And AMR genes were annotated and listed in <xref rid="tab1" ref-type="table">Table 1</xref>. The bacteria carried 17 AMR genes, including drug efflux-related, antibiotic target protection, antibiotic inactivation, and antibiotic target replacement genes, resulting in resistance against tetracycline, aminoglycosides, fluoroquinolones, macrolides, rifamycin, peptide antibiotics and cephalosporin, and other antibiotics. In addition, the AST results indicated that Pacne11-13 was multi-drug resistant to tetracycline, aminoglycosides, cephalosporins, and clindamycin (<xref rid="tab2" ref-type="table">Table 2</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Annotation of bacterial antibiotic-resistance genes of Pacne11-13.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Gene ID</th>
<th align="left" valign="top">ARO name</th>
<th align="left" valign="top">AMR gene family</th>
<th align="left" valign="top">Drug class</th>
<th align="left" valign="top">Resistance mechanism</th>
</tr>
</thead>
<tbody>
<tr>
<td align="char" valign="top" char=".">GM000034</td>
<td align="char" valign="top" char="&#x00B1;">mdtN</td>
<td align="char" valign="top" char="&#x00B1;">Major facilitator superfamily (MFS) antibiotic efflux pump</td>
<td align="char" valign="top" char="&#x00B1;">Acridine dye; disinfecting agents and intercalating dyes; nucleoside antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic efflux</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM000140</td>
<td align="char" valign="top" char="&#x00B1;">kdpE</td>
<td align="char" valign="top" char="&#x00B1;">kdpDE</td>
<td align="char" valign="top" char="&#x00B1;">Aminoglycoside antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic efflux</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM000202</td>
<td align="char" valign="top" char="&#x00B1;">efrB</td>
<td align="char" valign="top" char="&#x00B1;">ATP-binding cassette (ABC) antibiotic efflux pump</td>
<td align="char" valign="top" char="&#x00B1;">Fluoroquinolone antibiotic; macrolide antibiotic; rifamycin antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic efflux</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM000203</td>
<td align="char" valign="top" char="&#x00B1;">efrA</td>
<td align="char" valign="top" char="&#x00B1;">ATP-binding cassette (ABC) antibiotic efflux pump</td>
<td align="char" valign="top" char="&#x00B1;">Fluoroquinolone antibiotic; macrolide antibiotic; rifamycin antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic efflux</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM000393</td>
<td align="char" valign="top" char="&#x00B1;">mtrA</td>
<td align="char" valign="top" char="&#x00B1;">Resistance-nodulation-cell division (RND) antibiotic efflux pump</td>
<td align="char" valign="top" char="&#x00B1;">Macrolide antibiotic; penam</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic efflux</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM000404</td>
<td align="char" valign="top" char="&#x00B1;">adeH</td>
<td align="char" valign="top" char="&#x00B1;">Resistance-nodulation-cell division (RND) antibiotic efflux pump</td>
<td align="char" valign="top" char="&#x00B1;">Fluoroquinolone antibiotic; tetracycline antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic efflux</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM000492</td>
<td align="char" valign="top" char="&#x00B1;">AAC (3)-IIb</td>
<td align="char" valign="top" char="&#x00B1;">AAC (3)</td>
<td align="char" valign="top" char="&#x00B1;">Aminoglycoside antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic inactivation</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM000640</td>
<td align="char" valign="top" char="&#x00B1;">ugd</td>
<td align="char" valign="top" char="&#x00B1;">Pmr phosphoethanolamine transferase</td>
<td align="char" valign="top" char="&#x00B1;">Peptide antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic target alteration</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM000860</td>
<td align="char" valign="top" char="&#x00B1;">MexD</td>
<td align="char" valign="top" char="&#x00B1;">Resistance-nodulation-cell division (RND) antibiotic efflux pump</td>
<td align="char" valign="top" char="&#x00B1;">Aminocoumarin antibiotic; aminoglycoside antibiotic; cephalosporin; diaminopyrimidine antibiotic; fluoroquinolone antibiotic; macrolide antibiotic; penam; phenicol antibiotic; tetracycline antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic efflux</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM001163</td>
<td align="char" valign="top" char="&#x00B1;">Escherichia coli ampC1 beta-lactamase</td>
<td align="char" valign="top" char="&#x00B1;">AmpC-type beta-lactamase</td>
<td align="char" valign="top" char="&#x00B1;">Cephalosporin; penam</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic inactivation</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM001249</td>
<td align="char" valign="top" char="&#x00B1;">RbpA</td>
<td align="char" valign="top" char="&#x00B1;">RbpA bacterial RNA polymerase-binding protein</td>
<td align="char" valign="top" char="&#x00B1;">Rifamycin antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic target protection</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM001372</td>
<td align="char" valign="top" char="&#x00B1;">mtrA</td>
<td align="char" valign="top" char="&#x00B1;">Resistance-nodulation-cell division (RND) antibiotic efflux pump</td>
<td align="char" valign="top" char="&#x00B1;">Macrolide antibiotic; penam</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic efflux</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM001687</td>
<td align="char" valign="top" char="&#x00B1;">Trimethoprim-resistant dihydrofolate reductase DfrA43</td>
<td align="char" valign="top" char="&#x00B1;">Trimethoprim resistant dihydrofolate reductase dfr</td>
<td align="char" valign="top" char="&#x00B1;">Diaminopyrimidine antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic target replacement</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM001792</td>
<td align="char" valign="top" char="&#x00B1;">AAC (3)-IIb</td>
<td align="char" valign="top" char="&#x00B1;">AAC (3)</td>
<td align="char" valign="top" char="&#x00B1;">Aminoglycoside antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic inactivation</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM001899</td>
<td align="char" valign="top" char="&#x00B1;">Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin</td>
<td align="char" valign="top" char="&#x00B1;">Rifamycin-resistant beta-subunit of RNA polymerase (rpoB)</td>
<td align="char" valign="top" char="&#x00B1;">Peptide antibiotic; rifamycin antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic target alteration; antibiotic target replacement</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM002057</td>
<td align="char" valign="top" char="&#x00B1;">arlR</td>
<td align="char" valign="top" char="&#x00B1;">Major facilitator superfamily (MFS) antibiotic efflux pump</td>
<td align="char" valign="top" char="&#x00B1;">Acridine dye; disinfecting agents and intercalating dyes; fluoroquinolone antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic efflux</td>
</tr>
<tr>
<td align="char" valign="top" char=".">GM002320</td>
<td align="char" valign="top" char="&#x00B1;">msbA</td>
<td align="char" valign="top" char="&#x00B1;">ATP-binding cassette (ABC) antibiotic efflux pump</td>
<td align="char" valign="top" char="&#x00B1;">Nitroimidazole antibiotic</td>
<td align="char" valign="top" char="&#x00B1;">Antibiotic efflux</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>ARO, antibiotic resistance ontology; AMR, antimicrobial resistance.</p>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Antimicrobial susceptibility test.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Antibiotics</th>
<th align="center" valign="top">Diameter of zone of inhibition (mm)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="char" valign="top" char=".">Tetracycline</td>
<td align="char" valign="top" char="&#x00B1;">6.2&#x2009;+&#x2009;2.4</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Aminoglycosides</td>
<td align="char" valign="top" char="&#x00B1;">4.5&#x2013;0.3</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Cephalosporins</td>
<td align="char" valign="top" char="&#x00B1;">3.4&#x2009;+&#x2009;0.9</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Clindamycin</td>
<td align="char" valign="top" char="&#x00B1;">2.9&#x2009;+&#x2009;0.2</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Criteria: diameter of inhibition zone&#x2009;&#x003E;&#x2009;20&#x2009;mm, high sensitivity; 10&#x2009;~&#x2009;20&#x2009;mm, moderate sensitivity; &#x003C;&#x2009;10&#x2009;mm, resistant.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec15">
<title>Plaque and morphology of &#x03C6;PaP11-13</title>
<p>A <italic>P. acne</italic> phage was isolated from the sewage management center at Xinqiao Hospital and named &#x201C;&#x03C6;PaP11-13.&#x201D; This phage can form transparent circular plaques (diameter ranges from 1.0 to 5.0&#x2009;mm, <xref rid="fig1" ref-type="fig">Figure 1</xref>). TEM showed that &#x03C6;PaP11-13 had a polyhedron head (diameter 60&#x2009;&#x00B1;&#x2009;4.5&#x2009;nm) and an untraceable flexible tail (length 170&#x2009;&#x00B1;&#x2009;6.4&#x2009;nm, and width 14&#x2009;&#x00B1;&#x2009;2.4&#x2009;nm, <xref rid="fig2" ref-type="fig">Figure 2</xref>). These morphological features suggested that &#x03C6;PaP11-13 was a member of the Siphoviridae family.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Plaque pattern formed by &#x03C6;PaP11-13 lysis <italic>P. acne</italic>. The scale bar is 1&#x2009;cm.</p>
</caption>
<graphic xlink:href="fmicb-13-1065386-g001.tif"/>
</fig>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Transmission electron micrograph of &#x03C6;PaP11-13, negatively stained with 2% uranyl acetate.</p>
</caption>
<graphic xlink:href="fmicb-13-1065386-g002.tif"/>
</fig>
</sec>
<sec id="sec16">
<title>Optimal MOI and optimal adsorption time</title>
<p>Three groups of parallel experiments were conducted for MOI tests, and the optimal MOI of &#x03C6;PaP11-13 was 0.0100 (<xref rid="fig3" ref-type="fig">Figure 3</xref>). After 6&#x2009;h of incubation, the titers of &#x03C6;PaP11-13 were 2.7&#x2009;&#x00B1;&#x2009;0.6, 3.3&#x2009;&#x00B1;&#x2009;0.9, 3.3&#x2009;&#x00B1;&#x2009;0.4, 5.7&#x2009;&#x00B1;&#x2009;0.9, 2.3&#x2009;&#x00B1;&#x2009;1.1, 0.63&#x2009;&#x00B1;&#x2009;0.3&#x2009;&#x00D7;&#x2009;10<sup>7</sup> PFU/mL when the MOI was 10.0000, 1.0000, 0.1000, 0.0100, 0.0010, 0.0001. When incubated with host bacteria for 5, 10, and 15&#x2009;min, the titers of &#x03C6;PaP11-13 respectively, were 20.0&#x2009;&#x00B1;&#x2009;1.0, 1.56&#x2009;&#x00B1;&#x2009;3.1, and 3.4&#x2009;&#x00B1;&#x2009;0.9&#x2009;&#x00D7;&#x2009;10<sup>7</sup> PFU/mL, suggesting an optimal adsorption time of &#x03C6;PaP11-13 at 10&#x2009;min.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>The MOI test of &#x03C6;PaP11-13.</p>
</caption>
<graphic xlink:href="fmicb-13-1065386-g003.tif"/>
</fig>
</sec>
<sec id="sec17">
<title>One&#x2013;step growth curve</title>
<p>The one-step growth curve revealed the latency time and burst size of &#x03C6;PaP11-13. As shown in <xref rid="fig4" ref-type="fig">Figure 4</xref>, the titer decreased slightly in the first 10&#x2009;min but then remained stable for the first 5&#x2009;h but increased to a large degree in the next 5&#x2009;h, indicating that phage was released by the infected cells. Thus, the change in phage titer showed that &#x03C6;PaP11-13 had a long incubation period of approximately 5&#x2009;h, followed by a burst period, and then we can calculate the burst size. The phage titer reached a plateau about 10&#x2013;12&#x2009;h after co-culture. The burst size of &#x03C6;PaP11-13 is 26 PFU/cell.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>One-step growth curve. The incubation period was 5&#x2009;h, and the burst size was 26 PFU/cell.</p>
</caption>
<graphic xlink:href="fmicb-13-1065386-g004.tif"/>
</fig>
</sec>
<sec id="sec18">
<title>Stability of &#x03C6;PaP11-13</title>
<p>The stability of &#x03C6;PaP11-13 was tested under various temperatures, pH, and UV irradiation. Temperature stability results showed that the phage titer remained still from &#x2212;20 to 50&#x00B0;C. However, a temperature over 50&#x00B0;C would decrease phage titer rapidly to 0 (<xref rid="fig5" ref-type="fig">Figure 5A</xref>). In the acid&#x2013;base stability test, the pH tolerance of &#x03C6;PaP11-13 was stable from 2.0 to 12.0 (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). Moreover, the titer of &#x03C6;PaP11-13 decreased rapidly under UV irradiation and was utterly inactivated when the irradiation time reached 60&#x2009;min (<xref rid="fig5" ref-type="fig">Figure 5C</xref>). Chloroform had no significant effect on phage activity (<xref rid="fig5" ref-type="fig">Figure 5D</xref>).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>The stability of &#x03C6;PaP11-13, analyzed and plotted using GraphPad Prism version 9 <bold>(A)</bold> temperature stability. <bold>(B)</bold> pH stability. <bold>(C)</bold> Ultraviolet stability. <bold>(D)</bold> Chloroform stability.</p>
</caption>
<graphic xlink:href="fmicb-13-1065386-g005.tif"/>
</fig>
</sec>
<sec id="sec19">
<title>Host range analysis</title>
<p>A total of 16 strains of <italic>P. acne</italic> were involved in the analysis of the lytic range of &#x03C6;PaP11-13. The results showed that various-sized transparent plaques could be seen on most double-layer agar plates. The lysed rate of &#x03C6;PaP11-13 was 100% (16/16), demonstrating the phage has a broad host range (<xref rid="tab3" ref-type="table">Table 3</xref>).</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>The host range of &#x03C6;PaP11-13.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top"><italic>Propionibacterium acnes</italic></th>
<th align="center" valign="top">Lytic ability</th>
<th align="left" valign="top">Address</th>
</tr>
</thead>
<tbody>
<tr>
<td align="char" valign="top" char=".">Pacne11-07</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Pacne11-11</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Pacne11-12</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Pacne11-13</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Pacne11-14</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Pacne11-15</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Pacne11-16</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Pacne11-17</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Pacne11-18</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Pacne11-19</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Pacne11-20</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Cacne11-10</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Cacne11-11</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Cacne11-22</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Cacne11-23</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Cacne11-24</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">Xinqiao hospital</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec20">
<title>General genome characteristics and ORF analysis</title>
<p>The linear dsDNA genome of &#x03C6;PaP11-13 consisted of 29,648&#x2009;bp, with a G/C content of 54.08%. Forty five ORFs were predicted, accounting for 83.83% of the genome length, and the average length of each ORF was 606.22&#x2009;bp. Among the 45 predicted ORFs and 20 ORFs were largely matched to genes with annotation functions in the GenBank database. No non-coding RNA, antibiotic resistance, or virulence factors were found in the phage genome (<xref rid="tab4" ref-type="table">Table 4</xref>).</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>Gene annotation results of &#x03C6;PaP11-13.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">ORF</th>
<th align="center" valign="top">Direction</th>
<th align="center" valign="top">Start site</th>
<th align="center" valign="top">Stop site</th>
<th align="left" valign="top">Protein</th>
<th align="center" valign="top">Covery</th>
<th align="center" valign="top"><italic>E</italic>-value</th>
<th align="center" valign="top">Identity</th>
<th align="left" valign="top">Number</th>
</tr>
</thead>
<tbody>
<tr>
<td align="char" valign="top" char=".">1</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">97</td>
<td align="char" valign="top" char="&#x00B1;">386</td>
<td align="char" valign="top" char="&#x00B1;">HNH endonuclease</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">9.00<italic>E</italic>-53</td>
<td align="char" valign="top" char="&#x00B1;">85.42%</td>
<td align="char" valign="top" char="&#x00B1;">DAT38686.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">2</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">2,288</td>
<td align="char" valign="top" char="&#x00B1;">2,449</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">2.00<italic>E</italic>-20</td>
<td align="char" valign="top" char="&#x00B1;">75.44%</td>
<td align="char" valign="top" char="&#x00B1;">QPB11535.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">3</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">2,606</td>
<td align="char" valign="top" char="&#x00B1;">2,914</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">5.00<italic>E</italic>-64</td>
<td align="char" valign="top" char="&#x00B1;">95.10%</td>
<td align="char" valign="top" char="&#x00B1;">QPB11842.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">4</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">2,946</td>
<td align="char" valign="top" char="&#x00B1;">3,257</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">3.00<italic>E</italic>-67</td>
<td align="char" valign="top" char="&#x00B1;">95.15%</td>
<td align="char" valign="top" char="&#x00B1;">ATN87142.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">5</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">3,386</td>
<td align="char" valign="top" char="&#x00B1;">3,670</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">1.00<italic>E</italic>-57</td>
<td align="char" valign="top" char="&#x00B1;">89.36%</td>
<td align="char" valign="top" char="&#x00B1;">EAD6310181.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">6</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">3,754</td>
<td align="char" valign="top" char="&#x00B1;">4,290</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">97%</td>
<td align="char" valign="top" char="&#x00B1;">3.00<italic>E</italic>-45</td>
<td align="char" valign="top" char="&#x00B1;">73.14%</td>
<td align="char" valign="top" char="&#x00B1;">ATN87138.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">7</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">4,315</td>
<td align="char" valign="top" char="&#x00B1;">4,542</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">97%</td>
<td align="char" valign="top" char="&#x00B1;">5.00<italic>E</italic>-42</td>
<td align="char" valign="top" char="&#x00B1;">91.89%</td>
<td align="char" valign="top" char="&#x00B1;">DAQ10868.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">8</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">4,577</td>
<td align="char" valign="top" char="&#x00B1;">4,870</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">7.00<italic>E</italic>-13</td>
<td align="char" valign="top" char="&#x00B1;">84.54%</td>
<td align="char" valign="top" char="&#x00B1;">DAU50408.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">9</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">4,851</td>
<td align="char" valign="top" char="&#x00B1;">5,210</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">5.00<italic>E</italic>-64</td>
<td align="char" valign="top" char="&#x00B1;">94.96%</td>
<td align="char" valign="top" char="&#x00B1;">ATN90932.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">10</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">5,210</td>
<td align="char" valign="top" char="&#x00B1;">6,151</td>
<td align="char" valign="top" char="&#x00B1;">PD-(D/E)XK nuclease family protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">90.42%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009150041.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">11</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">6,148</td>
<td align="char" valign="top" char="&#x00B1;">6,558</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">2.00<italic>E</italic>-80</td>
<td align="char" valign="top" char="&#x00B1;">90.44%</td>
<td align="char" valign="top" char="&#x00B1;">ATN90930.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">12</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">6,610</td>
<td align="char" valign="top" char="&#x00B1;">7,068</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">5.00<italic>E</italic>-103</td>
<td align="char" valign="top" char="&#x00B1;">95.39%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009152440.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">13</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">7,111</td>
<td align="char" valign="top" char="&#x00B1;">7,974</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">94%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">97.21%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009152439.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">14</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">7,971</td>
<td align="char" valign="top" char="&#x00B1;">8,330</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">2.00<italic>E</italic>-77</td>
<td align="char" valign="top" char="&#x00B1;">94.96%</td>
<td align="char" valign="top" char="&#x00B1;">YP_008531712.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">15</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">8,474</td>
<td align="char" valign="top" char="&#x00B1;">9,199</td>
<td align="char" valign="top" char="&#x00B1;">DNA primase</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">2.00<italic>E</italic>-165</td>
<td align="char" valign="top" char="&#x00B1;">96.27%</td>
<td align="char" valign="top" char="&#x00B1;">ASJ79909.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">16</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">9,244</td>
<td align="char" valign="top" char="&#x00B1;">9,810</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">5.00<italic>E</italic>-124</td>
<td align="char" valign="top" char="&#x00B1;">96.28%</td>
<td align="char" valign="top" char="&#x00B1;">ASJ79910.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">17</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">9,807</td>
<td align="char" valign="top" char="&#x00B1;">10,367</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">1.00<italic>E</italic>-128</td>
<td align="char" valign="top" char="&#x00B1;">93.01%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009278006.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">18</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">10,383</td>
<td align="char" valign="top" char="&#x00B1;">10,545</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">5.00<italic>E</italic>-36</td>
<td align="char" valign="top" char="&#x00B1;">95.31%</td>
<td align="char" valign="top" char="&#x00B1;">QHB36816.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">19</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">10,542</td>
<td align="char" valign="top" char="&#x00B1;">11,588</td>
<td align="char" valign="top" char="&#x00B1;">Exonuclease</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">95.98%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009159989.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">20</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">11,598</td>
<td align="char" valign="top" char="&#x00B1;">11,918</td>
<td align="char" valign="top" char="&#x00B1;">Helix-turn-helix DNA binding domain protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">6.00<italic>E</italic>-72</td>
<td align="char" valign="top" char="&#x00B1;">100.00%</td>
<td align="char" valign="top" char="&#x00B1;">ATN90304.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">21</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">11,930</td>
<td align="char" valign="top" char="&#x00B1;">12,217</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">60%</td>
<td align="char" valign="top" char="&#x00B1;">5.00<italic>E</italic>-21</td>
<td align="char" valign="top" char="&#x00B1;">94.83%</td>
<td align="char" valign="top" char="&#x00B1;">YP_008531659.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">22</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">12,221</td>
<td align="char" valign="top" char="&#x00B1;">12,619</td>
<td align="char" valign="top" char="&#x00B1;">Sigma factor</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">1.00<italic>E</italic>-90</td>
<td align="char" valign="top" char="&#x00B1;">96.97%</td>
<td align="char" valign="top" char="&#x00B1;">YP_008531794.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">23</td>
<td align="char" valign="top" char="&#x00B1;">+</td>
<td align="char" valign="top" char="&#x00B1;">12,624</td>
<td align="char" valign="top" char="&#x00B1;">12,899</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">8.00<italic>E</italic>-52</td>
<td align="char" valign="top" char="&#x00B1;">91.21%</td>
<td align="char" valign="top" char="&#x00B1;">DAS49464.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">24</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">13,022</td>
<td align="char" valign="top" char="&#x00B1;">13,384</td>
<td align="char" valign="top" char="&#x00B1;">Holin</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">6.00<italic>E</italic>-75</td>
<td align="char" valign="top" char="&#x00B1;">93.33%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009160209.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">25</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">13,391</td>
<td align="char" valign="top" char="&#x00B1;">14,254</td>
<td align="char" valign="top" char="&#x00B1;">Amidase</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">96.17%</td>
<td align="char" valign="top" char="&#x00B1;">AGI12651.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">26</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">14,294</td>
<td align="char" valign="top" char="&#x00B1;">15,091</td>
<td align="char" valign="top" char="&#x00B1;">Collagen triple helix repeat protein</td>
<td align="char" valign="top" char="&#x00B1;">95%</td>
<td align="char" valign="top" char="&#x00B1;">2.00<italic>E</italic>-98</td>
<td align="char" valign="top" char="&#x00B1;">90.12%</td>
<td align="char" valign="top" char="&#x00B1;">DAU50379.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">27</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">15,094</td>
<td align="char" valign="top" char="&#x00B1;">15,357</td>
<td align="char" valign="top" char="&#x00B1;">Minor tail protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">3.00<italic>E</italic>-46</td>
<td align="char" valign="top" char="&#x00B1;">93.10%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009160161.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">28</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">15,403</td>
<td align="char" valign="top" char="&#x00B1;">16,221</td>
<td align="char" valign="top" char="&#x00B1;">H-type lectin domain-containing protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">96.32%</td>
<td align="char" valign="top" char="&#x00B1;">YP_008531652.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">29</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">16,238</td>
<td align="char" valign="top" char="&#x00B1;">17,395</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">97.14%</td>
<td align="char" valign="top" char="&#x00B1;">DAS61179.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">30</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">17,403</td>
<td align="char" valign="top" char="&#x00B1;">18,350</td>
<td align="char" valign="top" char="&#x00B1;">Tail family protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">98.41%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009150258.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">31</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">18,366</td>
<td align="char" valign="top" char="&#x00B1;">21,131</td>
<td align="char" valign="top" char="&#x00B1;">Tape measure protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">97.94%</td>
<td align="char" valign="top" char="&#x00B1;">QHB36803.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">32</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">21,139</td>
<td align="char" valign="top" char="&#x00B1;">21,426</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">3.00<italic>E</italic>-63</td>
<td align="char" valign="top" char="&#x00B1;">98.95%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009147237.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">33</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">21,525</td>
<td align="char" valign="top" char="&#x00B1;">21,821</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">6.00<italic>E</italic>-52</td>
<td align="char" valign="top" char="&#x00B1;">96.94%</td>
<td align="char" valign="top" char="&#x00B1;">WP_136662160.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">34</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">21,849</td>
<td align="char" valign="top" char="&#x00B1;">22,493</td>
<td align="char" valign="top" char="&#x00B1;">Major tail protein</td>
<td align="char" valign="top" char="&#x00B1;">86%</td>
<td align="char" valign="top" char="&#x00B1;">5.00<italic>E</italic>-135</td>
<td align="char" valign="top" char="&#x00B1;">98.45%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009149527.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">35</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">22,533</td>
<td align="char" valign="top" char="&#x00B1;">22,904</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">2.00<italic>E</italic>-77</td>
<td align="char" valign="top" char="&#x00B1;">94.31%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009150015.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">36</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">22,901</td>
<td align="char" valign="top" char="&#x00B1;">23,191</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">7.00<italic>E</italic>-43</td>
<td align="char" valign="top" char="&#x00B1;">94.79%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009151527.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">37</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">23,198</td>
<td align="char" valign="top" char="&#x00B1;">23,545</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">7.00<italic>E</italic>-78</td>
<td align="char" valign="top" char="&#x00B1;">98.26%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009148279.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">38</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">23,547</td>
<td align="char" valign="top" char="&#x00B1;">24,008</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">8.00<italic>E</italic>-94</td>
<td align="char" valign="top" char="&#x00B1;">96.08%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009146900.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">39</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">24,052</td>
<td align="char" valign="top" char="&#x00B1;">24,999</td>
<td align="char" valign="top" char="&#x00B1;">Capsid protein</td>
<td align="char" valign="top" char="&#x00B1;">90%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">98.99%</td>
<td align="char" valign="top" char="&#x00B1;">YP_008531596.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">40</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">25,006</td>
<td align="char" valign="top" char="&#x00B1;">25,557</td>
<td align="char" valign="top" char="&#x00B1;">Scaffold protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">7.00<italic>E</italic>-119</td>
<td align="char" valign="top" char="&#x00B1;">96.17%</td>
<td align="char" valign="top" char="&#x00B1;">ASJ79936.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">41</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">25,473</td>
<td align="char" valign="top" char="&#x00B1;">25,661</td>
<td align="char" valign="top" char="&#x00B1;">Hypothetical protein</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">1.00<italic>E</italic>-25</td>
<td align="char" valign="top" char="&#x00B1;">77.42%</td>
<td align="char" valign="top" char="&#x00B1;">DAU50426.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">42</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">25,662</td>
<td align="char" valign="top" char="&#x00B1;">26,417</td>
<td align="char" valign="top" char="&#x00B1;">MuF-like minor capsid protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">1.00<italic>E</italic>-164</td>
<td align="char" valign="top" char="&#x00B1;">96.02%</td>
<td align="char" valign="top" char="&#x00B1;">QHB36793.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">43</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">26,421</td>
<td align="char" valign="top" char="&#x00B1;">27,746</td>
<td align="char" valign="top" char="&#x00B1;">Portal protein</td>
<td align="char" valign="top" char="&#x00B1;">99%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">98.87%</td>
<td align="char" valign="top" char="&#x00B1;">ASJ79938.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">44</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">27,743</td>
<td align="char" valign="top" char="&#x00B1;">29,254</td>
<td align="char" valign="top" char="&#x00B1;">Terminase large subunit</td>
<td align="char" valign="top" char="&#x00B1;">96%</td>
<td align="char" valign="top" char="&#x00B1;">0</td>
<td align="char" valign="top" char="&#x00B1;">97.54%</td>
<td align="char" valign="top" char="&#x00B1;">YP_009159829.1</td>
</tr>
<tr>
<td align="char" valign="top" char=".">45</td>
<td align="char" valign="top" char="&#x00B1;">&#x2212;</td>
<td align="char" valign="top" char="&#x00B1;">29,259</td>
<td align="char" valign="top" char="&#x00B1;">29,507</td>
<td align="char" valign="top" char="&#x00B1;">Terminase small subunit</td>
<td align="char" valign="top" char="&#x00B1;">98%</td>
<td align="char" valign="top" char="&#x00B1;">5.00<italic>E</italic>-34</td>
<td align="char" valign="top" char="&#x00B1;">97.56%</td>
<td align="char" valign="top" char="&#x00B1;">QHB36790.1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>ORF, open reading frame.</p>
</table-wrap-foot>
</table-wrap>
<p>The predicted ORFs could be divided into four groups based on different functions: structural protein group, metabolism-related group, bacteria lysis group, and other functional groups. The structural protein contained minor tail protein (ORF34), H-type lectin domain-containing protein (ORF28), tail family protein (ORF30), tape measure protein (ORF31), major tail protein (ORF27), capsid protein (ORF39), scaffold protein (ORF40), MuF-like minor capsid protein (ORF42), and portal protein (ORF43). The metabolic-related group included HNH endonuclease (ORF1), P D-(D/E) X.K. nuclease family protein (ORF10), DNA Primase (ORF15), exonuclease (ORF19), helix-turn-helix DNA binding domain protein (ORF20), terminase large subunits (ORF44), and terminase small subunits (ORF45). The cleavage proteome included Amidase (ORF25) and Holin (ORF24). Other function groups include collagen triple helix repeat protein (ORF26) and sigma factor (ORF22). The annotation information of &#x03C6;PaP11-13 was uploaded to GenBank with the accession number: ON557706. The whole genome is visualized in <xref rid="fig6" ref-type="fig">Figure 6</xref>.</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>&#x03C6;PaP11-13 gene visualization. The middle number is the total length of the gene, and the circle diagram can be read from the inside out for G/C content, G/C ratio, transcription direction, and encoded protein. Different colors represent different functions. The outermost circles represent the 45 ORFs encoded by the genome, clockwise for the forward reading frame and counterclockwise for the reverse reading frame.</p>
</caption>
<graphic xlink:href="fmicb-13-1065386-g006.tif"/>
</fig>
</sec>
<sec id="sec21">
<title>Identification of phage proteins</title>
<p>SDS-PAGE was applied to verify the major proteins of &#x03C6;PaP11-13. The results showed clear protein bands and normal distribution (<xref rid="fig7" ref-type="fig">Figure 7A</xref>), indicating an undegraded phage protein preparation. Then all visible bands were cut and analyzed by LC&#x2013;MS/MS system. 17 phage proteins with high intensity were identified (<xref rid="tab5" ref-type="table">Table 5</xref>). As shown in <xref rid="fig7" ref-type="fig">Figure 7B</xref>, the bands were identified as the lysis-related proteins Holin (12.528&#x2009;kDa, ORF24), Amidase (31.354&#x2009;kDa, ORF25), and the tape measure protein (93.79&#x2009;kDa, ORF31). Furthermore, the molecular weight between 20 and 30&#x2009;kDa included scaffold protein (ORF40), major tail protein (ORF34), MuF-like minor capsid protein (ORF42), and H-type lectin domain-containing protein (ORF28); the molecular weight of 30&#x2013;40&#x2009;kDa included capsid protein (ORF39) and tail family protein (ORF30); molecular weight of 40&#x2013;50&#x2009;kDa included portal protein (ORF43).</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p><bold>(A)</bold> SDS-PAGE, <bold>(B)</bold> Protein analysis of &#x03C6;PaP11-13. The molecular weight histogram of protein. The ordinate is the molecular weight of the protein, and the abscissa is the number of proteins. The indicator lines classify and label proteins.</p>
</caption>
<graphic xlink:href="fmicb-13-1065386-g007.tif"/>
</fig>
<table-wrap position="float" id="tab5">
<label>Table 5</label>
<caption>
<p>Protein mass spectrometry of &#x03C6;PaP11-13.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Protein description</th>
<th align="left" valign="top">MW(kDa)</th>
<th align="left" valign="top">Intensity</th>
</tr>
</thead>
<tbody>
<tr>
<td align="char" valign="top" char=".">Holin</td>
<td align="char" valign="top" char=".">12.528</td>
<td align="char" valign="top" char="&#x00B1;">6,220,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Amidase</td>
<td align="char" valign="top" char=".">31.354</td>
<td align="char" valign="top" char="&#x00B1;">69,798,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">H-type lectin domain-containing protein</td>
<td align="char" valign="top" char=".">28.751</td>
<td align="char" valign="top" char="&#x00B1;">977,880,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Hypothetical protein</td>
<td align="char" valign="top" char=".">42.667</td>
<td align="char" valign="top" char="&#x00B1;">1,065,800,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Tail family protein</td>
<td align="char" valign="top" char=".">34.939</td>
<td align="char" valign="top" char="&#x00B1;">1,138,100,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Tape measure protein</td>
<td align="char" valign="top" char=".">93.79</td>
<td align="char" valign="top" char="&#x00B1;">304,070,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Hypothetical protein</td>
<td align="char" valign="top" char=".">10.595</td>
<td align="char" valign="top" char="&#x00B1;">10,955,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Major tail protein</td>
<td align="char" valign="top" char=".">23.06</td>
<td align="char" valign="top" char="&#x00B1;">15,828,000,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Hypothetical protein</td>
<td align="char" valign="top" char=".">13.59</td>
<td align="char" valign="top" char="&#x00B1;">79,012,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Hypothetical protein</td>
<td align="char" valign="top" char=".">13.109</td>
<td align="char" valign="top" char="&#x00B1;">4,946,200</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Hypothetical protein</td>
<td align="char" valign="top" char=".">16.349</td>
<td align="char" valign="top" char="&#x00B1;">318,010,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Capsid protein</td>
<td align="char" valign="top" char=".">32.709</td>
<td align="char" valign="top" char="&#x00B1;">20,596,000,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Scaffold protein</td>
<td align="char" valign="top" char=".">19.838</td>
<td align="char" valign="top" char="&#x00B1;">74,398,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">MuF-like minor capsid protein</td>
<td align="char" valign="top" char=".">27.834</td>
<td align="char" valign="top" char="&#x00B1;">39,025,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Portal protein</td>
<td align="char" valign="top" char=".">47.997</td>
<td align="char" valign="top" char="&#x00B1;">4,152,600,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Hypothetical protein</td>
<td align="char" valign="top" char=".">14.965</td>
<td align="char" valign="top" char="&#x00B1;">26,995,000</td>
</tr>
<tr>
<td align="char" valign="top" char=".">Hypothetical protein</td>
<td align="char" valign="top" char=".">16.805</td>
<td align="char" valign="top" char="&#x00B1;">3,582,000</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>MW, molecular weight.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec22">
<title>Collinearity and phylogenetic analysis</title>
<p>By comparing with the whole genome sequence in the NCBI database, the similarity between &#x03C6;PaP11-13 and known Sipoviridae family phages ranged from 41 to 98% (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S1</xref>). The two phages with the highest similarity to &#x03C6;PaP11-13 were &#x03C6;PA6 (dq4431235.1, 98%) and &#x03C6;ct4Al2 (BK053742.1, 98%). However, the collinearity analysis revealed multiple local collinearity regions (LCB) between &#x03C6;PaP11-13 and these known phages. And these LCBs were rearranged and inverted. Even some genes within each LCB were distinct, with variants, rearrangements, and insertions (<xref rid="fig8" ref-type="fig">Figure 8</xref>). Collinearity analysis indicated that although &#x03C6;PaP11-13 was similar to these phages, there were significant internal differences (Orthologs and common conserved region sequence are listed in <xref ref-type="supplementary-material" rid="SM3">Supplementary Tables S2</xref>, <xref ref-type="supplementary-material" rid="SM4">S3</xref>). Phylogenetic trees were constructed based on the terminal large subunit protein because its amino acid sequence was highly conserved. As shown in <xref rid="fig9" ref-type="fig">Figure 9</xref>, &#x03C6;PaP11-13 and &#x03C6;PHL030N00 (KJ578760.1), a <italic>P. acne</italic> phage belonging to the Sipoviridae family, were on the same branch, with 100% reliability and short genetic distance, revealing the homology between &#x03C6;PaP11-13 and &#x03C6;PHL030N00. Collinearity and phylogenetic analysis confirmed <italic>P. acne</italic> phage &#x03C6;PaP11-13 as a member of the Sipoviridae family.</p>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption>
<p>Collinearity analysis of &#x03C6;PaP11-13. From top to bottom are &#x03C6;PaP11-13, &#x03C6;PA6(98%), &#x03C6;PHL116M10(97%), &#x03C6;P107A(96%), &#x03C6;PAD20 (95%). The same color block represents the LCB. Blank regions inside and outside the LCB region represent regions of difference between genomes.</p>
</caption>
<graphic xlink:href="fmicb-13-1065386-g008.tif"/>
</fig>
<fig position="float" id="fig9">
<label>Figure 9</label>
<caption>
<p>Phylogenetic analysis of &#x03C6;PaP11-13. The number in the phylogenetic tree is the phage accession number, and the number on the branch represents the reliability.</p>
</caption>
<graphic xlink:href="fmicb-13-1065386-g009.tif"/>
</fig>
</sec>
</sec>
<sec id="sec23" sec-type="discussions">
<title>Discussion</title>
<p><italic>P. acne</italic> is not only a commensal bacterium that inhabits the sebaceous follicle but is also one of the primary acne triggers (<xref ref-type="bibr" rid="ref9">Dreno et al., 2017</xref>). Prevention or removal of the <italic>P. acne</italic> infection can reduce the incidence and inflammation of severe acne vulgaris (<xref ref-type="bibr" rid="ref33">Oge et al., 2019</xref>). The first-line treatment for severe acne vulgaris is still systematic antibiotic therapy (<xref ref-type="bibr" rid="ref19">Hauk, 2017</xref>). But its side effects and increasing antibiotic resistance bring troubles. Antibiotic-resistant <italic>P. acne</italic>s-induced acne vulgaris has multiplied from 20% in the 20th century to 64% in the 21st century (<xref ref-type="bibr" rid="ref41">Toyne et al., 2012</xref>) in Australia. Even in this study, we found 17 AMR genes in clinical strain, Pacne11-13, multi-drug resistant to almost all first-line antibiotics. The harsh situation brings trouble to clinical practice. Thus, it is urgent to explore new treatments for severe acne vulgaris caused by antibiotic-resistant <italic>P. acne</italic>. The discovery of <italic>P. acnes</italic> phage has a long history. In 1964, <italic>P. acnes</italic> phages were first identified (<xref ref-type="bibr" rid="ref5">Brzin, 1964</xref>), and <xref ref-type="bibr" rid="ref47">Zierdt et al. (1968)</xref> isolated phage 174 from <italic>Corynebacterium acnes</italic> strain and found that 88% of the <italic>P. acnes</italic> strain was sensitive to this phage. In 1974, they studied the biological characteristics of nine <italic>P. acne</italic> phages and found they were all with long, curved nonretractile tails and had good resistance to temperature and pH (<xref ref-type="bibr" rid="ref46">Zierdt, 1974</xref>). In 2007, Farrar first reported the genome sequence of <italic>P. acne</italic> phage PA6 and demonstrated it without the virulence gene (<xref ref-type="bibr" rid="ref11">Farrar et al., 2007</xref>). Phages are new alternatives to treating antibiotic-resistant bacteria (<xref ref-type="bibr" rid="ref8">Ding et al., 2022</xref>). In this study, we isolated a lytic phage &#x03C6;PaP11-13 against a clinical multi-drug resistant <italic>P. acne</italic> strain Pacne11-13 with a typical Siphovirus morphology, icosahedral structure, an untraceable flexible tail, and a polyhedral head.</p>
<p>The one-step growth curve may provide intrinsic working rules of a target phage. However, there were few reports on one-step growth curves for <italic>P. acne</italic> phages but contradictory descriptions (<xref ref-type="bibr" rid="ref29">Marinelli et al., 2012</xref>; <xref ref-type="bibr" rid="ref4">Br&#x00FC;ggemann and Lood, 2013</xref>). We managed to curve the one-step growth curve of &#x03C6;PaP11-13 after repeated experiments. <italic>Propionibacterium</italic> phages seem to have a more extended incubation time and a less rapid lysis period, which might be addressed to the host growth speed (<xref ref-type="bibr" rid="ref32">Nakase et al., 2018</xref>).</p>
<p>From the application perspective, not only are particular phage screening and animal experiments increasing, but the corresponding clinical applications for treating diseases caused by drug-resistant bacteria are also increasing. In 2018, America reported a case of successful treatment of multidrug-resistant <italic>Acinetobacter baumannii</italic> infection with phages; In 2022, France reported the treatment of three patients with recurrent Staphylococcus aureus prosthesis knee infection (PKI), in which phage showed good efficacy (<xref ref-type="bibr" rid="ref25">LaVergne et al., 2018</xref>; <xref ref-type="bibr" rid="ref13">Ferry et al., 2022</xref>). Recently, a phase I clinical trial on topical applied <italic>P. acne</italic> phages treating antibiotic-resistant acne vulgaris successfully in the United States (<xref ref-type="bibr" rid="ref17">Golembo et al., 2022</xref>). Besides, our team performed animal experiments demonstrating that phage therapy was as effective as antibiotic therapy. <italic>P. acne</italic> phages were also found to affect immunomodulators when evaluating the severity of inflammation of acne rats (data not shown). To understand the feasibility of phage therapy, it is necessary to comprehend phage&#x2019;s biological characteristics. According to their characteristics, different administration methods, such as oral administration, injection, and application, are selected to reduce the influence on bacteriophage activity. Additionally, &#x03C6;PaP11-13 is functionally stable over a wide range of pH values and temperatures, potentially suitable in the human physiological environment. And the inactivation of &#x03C6;PaP11-13 under ultraviolet irradiation suggests a further application with sunscreen or at night to ensure the therapeutic effect on severe acne vulgaris. The stability of bacteriophages are mainly determined by their morphology and structure. Most <italic>P. acne</italic> phages reported belonged to the Siphoviridae family, sharing a similar morphology, with long tails and icosahedral heads, and thus performed the same stability (<xref ref-type="bibr" rid="ref46">Zierdt, 1974</xref>; <xref ref-type="bibr" rid="ref29">Marinelli et al., 2012</xref>). Due to the diversity and specificity between phages and their hosts, &#x03C6;PaP11-13 remains a potential candidate in our local country when the genomic background is thoroughly understood.</p>
<p>The genome of &#x03C6;PaP11-13 is linear dsDNA with a length of 29,648&#x2009;bp, which is consistent with most phages of the Siphoviridae family. Although the similarity between the &#x03C6;PaP11-13 genome and known Sipoviridae family viruses ranged from 41 to 98%, our collinearity analysis suggests &#x03C6;PaP11-13 as a novel <italic>P. acne</italic> phage.</p>
<p>The high mutation rate of phages makes identifying gene function difficult (<xref ref-type="bibr" rid="ref18">Gordillo Altamirano and Barr, 2019</xref>). Among the 45 predicted ORFs, only 20 ORFs have been annotated with their specific functions. The annotation suggests &#x03C6;PaP11-13 has two main lysis-related proteins: Holin (ORF25)and Amidase (ORF26), and their gene sequences are 99% similar to the known <italic>P. acne</italic> phages. They perform the lysis of host bacteria, which could produce synergistic effects during the lysis process (<xref ref-type="bibr" rid="ref12">Fernandes and S&#x00E3;o-Jos&#x00E9;, 2016</xref>) and even serve as independent antibiotics (<xref ref-type="bibr" rid="ref16">Ghosh et al., 2019</xref>). Non-coding RNA genes and virulence factors were not found, making it safer for further applications. However, more transcriptomic analysis between the phage and host would help enrich an understanding and provide the basis for further research (<xref ref-type="bibr" rid="ref44">Yang et al., 2019c</xref>).</p>
</sec>
<sec id="sec24" sec-type="conclusions">
<title>Conclusion</title>
<p>&#x03C6;PaP11-13 is a member of the Sipoviridae family, with good stability, strong lysis ability, and without virulence. It was identified as a new <italic>P. acne</italic> phage by biological characterization and genome analysis. Its discovery enriches the phage library of <italic>P. acne</italic> and provides the basis for the clinical application of phage therapy for antibiotics-resistant <italic>P. acne</italic>-induced severe acne vulgaris.</p>
</sec>
<sec id="sec25" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found at: <ext-link xlink:href="http://ncbi.nlm.nih.gov/nuccore/ON557706" ext-link-type="uri">ncbi.nlm.nih.gov/nuccore/ON557706</ext-link>.</p>
</sec>
<sec id="sec26">
<title>Ethics statement</title>
<p>This is an original article on bacteriophages and bacteria. For this type of study, the requirement for ethics approval is waived by the Medical Ethics Committee of the Second Affiliated Hospital (Xinqiao Hospital) of Army Medical University, PLA.</p>
</sec>
<sec id="sec27">
<title>Author contributions</title>
<p>DL, YZ, and ZY conceived and designed the experiments. DL performed the experiments. JZ, RL, KC, YL, YS, and XS analyzed the data. DL and ZY wrote the paper. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="sec28" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (grant nos. 82002051), the Natural Science Foundation of Chongqing CSTC (cstc2021jcyj-msxmX0655), and the Doctor Through Line Project of Chongqing CSTB (CSTB2022BSXM-JCX0019).</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="sec30" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2022.1065386/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2022.1065386/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.TIF" id="SM1" mimetype="image/tiff" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure S1</label>
<caption>
<p>The grown curve of Pacne11-13.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_6.DOCX" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_7.DOCX" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_8.DOCX" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arndt</surname> <given-names>D.</given-names></name> <name><surname>Grant</surname> <given-names>J. R.</given-names></name> <name><surname>Marcu</surname> <given-names>A.</given-names></name> <name><surname>Sajed</surname> <given-names>T.</given-names></name> <name><surname>Pon</surname> <given-names>A.</given-names></name> <name><surname>Liang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>PHASTER: a better, faster version of the PHAST phage search tool</article-title>. <source>Nucleic Acids Res.</source> <volume>44</volume>, <fpage>W16</fpage>&#x2013;<lpage>W21</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkw387</pub-id>, PMID: <pub-id pub-id-type="pmid">27141966</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname> <given-names>R. K.</given-names></name> <name><surname>Bartels</surname> <given-names>D.</given-names></name> <name><surname>Best</surname> <given-names>A. A.</given-names></name> <name><surname>DeJongh</surname> <given-names>M.</given-names></name> <name><surname>Disz</surname> <given-names>T.</given-names></name> <name><surname>Edwards</surname> <given-names>R. A.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>The RAST server: rapid annotations using subsystems technology</article-title>. <source>BMC Genomics</source> <volume>9</volume>:<fpage>75</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2164-9-75</pub-id>, PMID: <pub-id pub-id-type="pmid">18261238</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brettin</surname> <given-names>T.</given-names></name> <name><surname>Davis</surname> <given-names>J. J.</given-names></name> <name><surname>Disz</surname> <given-names>T.</given-names></name> <name><surname>Edwards</surname> <given-names>R. A.</given-names></name> <name><surname>Gerdes</surname> <given-names>S.</given-names></name> <name><surname>Olsen</surname> <given-names>G. J.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes</article-title>. <source>Sci. Rep.</source> <volume>5</volume>:<fpage>8365</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep08365</pub-id>, PMID: <pub-id pub-id-type="pmid">25666585</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Br&#x00FC;ggemann</surname> <given-names>H.</given-names></name> <name><surname>Lood</surname> <given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Bacteriophages infecting <italic>Propionibacterium acnes</italic></article-title>. <source>Biomed. Res. Int.</source> <volume>2013</volume>:<fpage>705741</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2013/705741</pub-id>, PMID: <pub-id pub-id-type="pmid">23691509</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brzin</surname> <given-names>B.</given-names></name></person-group> (<year>1964</year>). <article-title>Studies on the CORYNEBACTERIUM acnes</article-title>. <source>Acta Pathol. Microbiol. Scand.</source> <volume>60</volume>, <fpage>599</fpage>&#x2013;<lpage>608</lpage>. doi: <pub-id pub-id-type="doi">10.1111/apm.1964.60.4.599</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>C. W.</given-names></name> <name><surname>Choi</surname> <given-names>J. W.</given-names></name> <name><surname>Park</surname> <given-names>K. C.</given-names></name> <name><surname>Youn</surname> <given-names>S. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Ultraviolet-induced red fluorescence of patients with acne reflects regional casual sebum level and acne lesion distribution: qualitative and quantitative analyses of facial fluorescence</article-title>. <source>Br. J. Dermatol.</source> <volume>166</volume>, <fpage>59</fpage>&#x2013;<lpage>66</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2133.2011.10598.x</pub-id>, PMID: <pub-id pub-id-type="pmid">21895623</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darling</surname> <given-names>A. C.</given-names></name> <name><surname>Mau</surname> <given-names>B.</given-names></name> <name><surname>Blattner</surname> <given-names>F. R.</given-names></name> <name><surname>Perna</surname> <given-names>N. T.</given-names></name></person-group> (<year>2004</year>). <article-title>Mauve: multiple alignment of conserved genomic sequence with rearrangements</article-title>. <source>Genome Res.</source> <volume>14</volume>, <fpage>1394</fpage>&#x2013;<lpage>1403</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gr.2289704</pub-id>, PMID: <pub-id pub-id-type="pmid">15231754</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>X.</given-names></name> <name><surname>Tang</surname> <given-names>Q.</given-names></name> <name><surname>Xu</surname> <given-names>Z.</given-names></name> <name><surname>Xu</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Zheng</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Challenges and innovations in treating chronic and acute wound infections: from basic science to clinical practice</article-title>. <source>Burns Trauma</source> <volume>10</volume>. doi: <pub-id pub-id-type="doi">10.1093/burnst/tkac014</pub-id>, PMID: <pub-id pub-id-type="pmid">35611318</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dreno</surname> <given-names>B.</given-names></name> <name><surname>Martin</surname> <given-names>R.</given-names></name> <name><surname>Moyal</surname> <given-names>D.</given-names></name> <name><surname>Henley</surname> <given-names>J. B.</given-names></name> <name><surname>Khammari</surname> <given-names>A.</given-names></name> <name><surname>Seit&#x00E9;</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Skin microbiome and acne vulgaris: staphylococcus, a new actor in acne</article-title>. <source>Exp. Dermatol.</source> <volume>26</volume>, <fpage>798</fpage>&#x2013;<lpage>803</lpage>. doi: <pub-id pub-id-type="doi">10.1111/exd.13296</pub-id>, PMID: <pub-id pub-id-type="pmid">28094874</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dr&#x00E9;no</surname> <given-names>B.</given-names></name> <name><surname>P&#x00E9;castaings</surname> <given-names>S.</given-names></name> <name><surname>Corvec</surname> <given-names>S.</given-names></name> <name><surname>Veraldi</surname> <given-names>S.</given-names></name> <name><surname>Khammari</surname> <given-names>A.</given-names></name> <name><surname>Roques</surname> <given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title><italic>Cutibacterium acnes</italic> (<italic>Propionibacterium acnes</italic>) and acne vulgaris: a brief look at the latest updates</article-title>. <source>J. Eur. Acad. Dermatol. Venereol.</source> <volume>32</volume>, <fpage>5</fpage>&#x2013;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jdv.15043</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farrar</surname> <given-names>M. D.</given-names></name> <name><surname>Howson</surname> <given-names>K. M.</given-names></name> <name><surname>Bojar</surname> <given-names>R. A.</given-names></name> <name><surname>West</surname> <given-names>D.</given-names></name> <name><surname>Towler</surname> <given-names>J. C.</given-names></name> <name><surname>Parry</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Genome sequence and analysis of a <italic>Propionibacterium acnes</italic> bacteriophage</article-title>. <source>J. Bacteriol.</source> <volume>189</volume>, <fpage>4161</fpage>&#x2013;<lpage>4167</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.00106-07</pub-id>, PMID: <pub-id pub-id-type="pmid">17400737</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname> <given-names>S.</given-names></name> <name><surname>S&#x00E3;o-Jos&#x00E9;</surname> <given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>More than a hole: the holin lethal function may be required to fully sensitize bacteria to the lytic action of canonical endolysins</article-title>. <source>Mol. Microbiol.</source> <volume>102</volume>, <fpage>92</fpage>&#x2013;<lpage>106</lpage>. doi: <pub-id pub-id-type="doi">10.1111/mmi.13448</pub-id>, PMID: <pub-id pub-id-type="pmid">27328857</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferry</surname> <given-names>T.</given-names></name> <name><surname>Kolenda</surname> <given-names>C.</given-names></name> <name><surname>Laurent</surname> <given-names>F.</given-names></name> <name><surname>Leboucher</surname> <given-names>G.</given-names></name> <name><surname>Merabischvilli</surname> <given-names>M.</given-names></name> <name><surname>Djebara</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Personalized bacteriophage therapy to treat pandrug-resistant spinal <italic>Pseudomonas aeruginosa</italic> infection</article-title>. <source>Nat. Commun.</source> <volume>13</volume>:<fpage>4239</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-022-31837-9</pub-id>, PMID: <pub-id pub-id-type="pmid">35869081</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname> <given-names>L.</given-names></name> <name><surname>Csongradi</surname> <given-names>C.</given-names></name> <name><surname>Aucamp</surname> <given-names>M.</given-names></name> <name><surname>du Plessis</surname> <given-names>J.</given-names></name> <name><surname>Gerber</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Treatment modalities for acne</article-title>. <source>Molecules</source> <volume>21</volume>. doi: <pub-id pub-id-type="doi">10.3390/molecules21081063</pub-id>, PMID: <pub-id pub-id-type="pmid">27529209</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garneau</surname> <given-names>J. R.</given-names></name> <name><surname>Depardieu</surname> <given-names>F.</given-names></name> <name><surname>Fortier</surname> <given-names>L.-C.</given-names></name> <name><surname>Bikard</surname> <given-names>D.</given-names></name> <name><surname>Monot</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>PhageTerm: a tool for fast and accurate determination of phage termini and packaging mechanism using next-generation sequencing data</article-title>. <source>Sci. Rep.</source> <volume>7</volume>:<fpage>8292</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-017-07910-5</pub-id>, PMID: <pub-id pub-id-type="pmid">28811656</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname> <given-names>C.</given-names></name> <name><surname>Sarkar</surname> <given-names>P.</given-names></name> <name><surname>Issa</surname> <given-names>R.</given-names></name> <name><surname>Haldar</surname> <given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Alternatives to conventional antibiotics in the era of antimicrobial resistance</article-title>. <source>Trends Microbiol.</source> <volume>27</volume>, <fpage>323</fpage>&#x2013;<lpage>338</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tim.2018.12.010</pub-id>, PMID: <pub-id pub-id-type="pmid">30683453</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Golembo</surname> <given-names>M.</given-names></name> <name><surname>Puttagunta</surname> <given-names>S.</given-names></name> <name><surname>Rappo</surname> <given-names>U.</given-names></name> <name><surname>Weinstock</surname> <given-names>E.</given-names></name> <name><surname>Engelstein</surname> <given-names>R.</given-names></name> <name><surname>Gahali-Sass</surname> <given-names>I.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Development of a topical bacteriophage gel targeting <italic>Cutibacterium acnes</italic> for acne prone skin and results of a phase 1 cosmetic randomized clinical trial</article-title>. <source>Skin Health Dis.</source> <volume>2</volume>:<fpage>e93</fpage>. doi: <pub-id pub-id-type="doi">10.1002/ski2.93</pub-id>, PMID: <pub-id pub-id-type="pmid">35677920</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gordillo Altamirano</surname> <given-names>F. L.</given-names></name> <name><surname>Barr</surname> <given-names>J. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Phage therapy in the postantibiotic era</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>32</volume>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00066-18</pub-id>, PMID: <pub-id pub-id-type="pmid">30651225</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hauk</surname> <given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Acne vulgaris: treatment guidelines from the AAD</article-title>. <source>Am. Fam. Physician</source> <volume>95</volume>, <fpage>740</fpage>&#x2013;<lpage>741</lpage>.</citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>G.</given-names></name> <name><surname>Shen</surname> <given-names>X.</given-names></name> <name><surname>Gong</surname> <given-names>Y.</given-names></name> <name><surname>Dong</surname> <given-names>Z.</given-names></name> <name><surname>Zhao</surname> <given-names>X.</given-names></name> <name><surname>Shen</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Antibacterial properties of <italic>Acinetobacter baumannii</italic> phage Abp1 endolysin (PlyAB1)</article-title>. <source>BMC Infect. Dis.</source> <volume>14</volume>:<fpage>681</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12879-014-0681-2</pub-id>, PMID: <pub-id pub-id-type="pmid">25495514</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kortright</surname> <given-names>K. E.</given-names></name> <name><surname>Chan</surname> <given-names>B. K.</given-names></name> <name><surname>Koff</surname> <given-names>J. L.</given-names></name> <name><surname>Turner</surname> <given-names>P. E.</given-names></name></person-group> (<year>2019</year>). <article-title>Phage therapy: a renewed approach to combat antibiotic-resistant bacteria</article-title>. <source>Cell Host Microbe</source> <volume>25</volume>, <fpage>219</fpage>&#x2013;<lpage>232</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2019.01.014</pub-id>, PMID: <pub-id pub-id-type="pmid">30763536</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kropinski</surname> <given-names>A. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Practical advice on the one-step growth curve</article-title>. <source>Methods Mol. Biol.</source> <volume>1681</volume>, <fpage>41</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-4939-7343-9_3</pub-id>, PMID: <pub-id pub-id-type="pmid">29134585</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>S.</given-names></name> <name><surname>Stecher</surname> <given-names>G.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Knyaz</surname> <given-names>C.</given-names></name> <name><surname>Tamura</surname> <given-names>K.</given-names></name></person-group> (<year>2018</year>). <article-title>MEGA X: molecular evolutionary genetics analysis across computing platforms</article-title>. <source>Mol. Biol. Evol.</source> <volume>35</volume>, <fpage>1547</fpage>&#x2013;<lpage>1549</lpage>. doi: <pub-id pub-id-type="doi">10.1093/molbev/msy096</pub-id>, PMID: <pub-id pub-id-type="pmid">29722887</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname> <given-names>H. Y. P.</given-names></name> <name><surname>Lai</surname> <given-names>M.-J.</given-names></name> <name><surname>Chen</surname> <given-names>T.-Y.</given-names></name> <name><surname>Wu</surname> <given-names>W.-J.</given-names></name> <name><surname>Peng</surname> <given-names>S.-Y.</given-names></name> <name><surname>Chang</surname> <given-names>K.-C.</given-names></name></person-group> (<year>2021</year>). <article-title>Therapeutic effect of a newly isolated lytic bacteriophage against multi-drug-resistant <italic>Cutibacterium acnes</italic> infection in mice</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>. doi: <pub-id pub-id-type="doi">10.3390/ijms22137031</pub-id>, PMID: <pub-id pub-id-type="pmid">34209998</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LaVergne</surname> <given-names>S.</given-names></name> <name><surname>Hamilton</surname> <given-names>T.</given-names></name> <name><surname>Biswas</surname> <given-names>B.</given-names></name> <name><surname>Kumaraswamy</surname> <given-names>M.</given-names></name> <name><surname>Schooley</surname> <given-names>R. T.</given-names></name> <name><surname>Wooten</surname> <given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Phage therapy for a multidrug-resistant <italic>Acinetobacter baumannii</italic> craniectomy site infection. Open forum</article-title>. <source>Infect. Dis.</source> <volume>5</volume>:<fpage>ofy064</fpage>. doi: <pub-id pub-id-type="doi">10.1093/ofid/ofy064</pub-id>, PMID: <pub-id pub-id-type="pmid">29687015</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lavers</surname> <given-names>I.</given-names></name> <name><surname>Courtenay</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>A practical approach to the treatment of acne vulgaris</article-title>. <source>Nurs. Stand.</source> <volume>25</volume>, <fpage>55</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.7748/ns.25.19.55.s53</pub-id>, PMID: <pub-id pub-id-type="pmid">21287928</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>B.</given-names></name> <name><surname>Pop</surname> <given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>ARDB--antibiotic resistance genes database</article-title>. <source>Nucleic Acids Res.</source> <volume>37</volume>, <fpage>D443</fpage>&#x2013;<lpage>D447</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkn656</pub-id>, PMID: <pub-id pub-id-type="pmid">18832362</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lynn</surname> <given-names>D. D.</given-names></name> <name><surname>Umari</surname> <given-names>T.</given-names></name> <name><surname>Dunnick</surname> <given-names>C. A.</given-names></name> <name><surname>Dellavalle</surname> <given-names>R. P.</given-names></name></person-group> (<year>2016</year>). <article-title>The epidemiology of acne vulgaris in late adolescence</article-title>. <source>Adolesc. Health Med. Ther.</source> <volume>7</volume>, <fpage>13</fpage>&#x2013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.2147/AHMT.S55832</pub-id>, PMID: <pub-id pub-id-type="pmid">26955297</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marinelli</surname> <given-names>L. J.</given-names></name> <name><surname>Fitz-Gibbon</surname> <given-names>S.</given-names></name> <name><surname>Hayes</surname> <given-names>C.</given-names></name> <name><surname>Bowman</surname> <given-names>C.</given-names></name> <name><surname>Inkeles</surname> <given-names>M.</given-names></name> <name><surname>Loncaric</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title><italic>Propionibacterium acnes</italic> bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates</article-title>. <source>MBio</source> <volume>3</volume>. doi: <pub-id pub-id-type="doi">10.1128/mBio.00279-12</pub-id>, PMID: <pub-id pub-id-type="pmid">23015740</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mendoza</surname> <given-names>N.</given-names></name> <name><surname>Hernandez</surname> <given-names>P. O.</given-names></name> <name><surname>Tyring</surname> <given-names>S. K.</given-names></name> <name><surname>Haitz</surname> <given-names>K. A.</given-names></name> <name><surname>Motta</surname> <given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Antimicrobial susceptibility of <italic>Propionibacterium acnes</italic> isolates from acne patients in Colombia</article-title>. <source>Int. J. Dermatol.</source> <volume>52</volume>, <fpage>688</fpage>&#x2013;<lpage>692</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-4632.2011.05403.x</pub-id>, PMID: <pub-id pub-id-type="pmid">23451873</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakase</surname> <given-names>K.</given-names></name> <name><surname>Nakaminami</surname> <given-names>H.</given-names></name> <name><surname>Takenaka</surname> <given-names>Y.</given-names></name> <name><surname>Hayashi</surname> <given-names>N.</given-names></name> <name><surname>Kawashima</surname> <given-names>M.</given-names></name> <name><surname>Noguchi</surname> <given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title><italic>Propionibacterium acnes</italic> is developing gradual increase in resistance to oral tetracyclines</article-title>. <source>J. Med. Microbiol.</source> <volume>66</volume>, <fpage>8</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1099/jmm.0.000392</pub-id>, PMID: <pub-id pub-id-type="pmid">28218057</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakase</surname> <given-names>K.</given-names></name> <name><surname>Okamoto</surname> <given-names>Y.</given-names></name> <name><surname>Aoki</surname> <given-names>S.</given-names></name> <name><surname>Noguchi</surname> <given-names>N.</given-names></name></person-group> (<year>2018</year>). <article-title>Long-term administration of oral macrolides for acne treatment increases macrolide-resistant <italic>Propionibacterium acnes</italic></article-title>. <source>J. Dermatol.</source> <volume>45</volume>, <fpage>340</fpage>&#x2013;<lpage>343</lpage>. doi: <pub-id pub-id-type="doi">10.1111/1346-8138.14178</pub-id>, PMID: <pub-id pub-id-type="pmid">29235673</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oge</surname> <given-names>L. K.</given-names></name> <name><surname>Broussard</surname> <given-names>A.</given-names></name> <name><surname>Marshall</surname> <given-names>M. D.</given-names></name></person-group> (<year>2019</year>). <article-title>Acne vulgaris: diagnosis and treatment</article-title>. <source>Am. Fam. Physician</source> <volume>100</volume>, <fpage>475</fpage>&#x2013;<lpage>484</lpage>.</citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oprica</surname> <given-names>C.</given-names></name> <name><surname>Emtestam</surname> <given-names>L.</given-names></name> <name><surname>Lapins</surname> <given-names>J.</given-names></name> <name><surname>Borglund</surname> <given-names>E.</given-names></name> <name><surname>Nyberg</surname> <given-names>F.</given-names></name> <name><surname>Stenlund</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Antibiotic-resistant <italic>Propionibacterium acnes</italic> on the skin of patients with moderate to severe acne in stockholm</article-title>. <source>Anaerobe</source> <volume>10</volume>, <fpage>155</fpage>&#x2013;<lpage>164</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.anaerobe.2004.02.002</pub-id>, PMID: <pub-id pub-id-type="pmid">16701513</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schuetz</surname> <given-names>A. N.</given-names></name></person-group> (<year>2014</year>). <article-title>Antimicrobial resistance and susceptibility testing of anaerobic bacteria</article-title>. <source>Clin. Infect. Dis.</source> <volume>59</volume>, <fpage>698</fpage>&#x2013;<lpage>705</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cid/ciu395</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Yang</surname> <given-names>Z.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>You</surname> <given-names>B.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Characterization and genome sequencing of a novel T7-like lytic phage, kpssk3, infecting carbapenem-resistant <italic>Klebsiella pneumoniae</italic></article-title>. <source>Arch. Virol.</source> <volume>165</volume>, <fpage>97</fpage>&#x2013;<lpage>104</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00705-019-04447-y</pub-id>, PMID: <pub-id pub-id-type="pmid">31734749</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>Y.</given-names></name> <name><surname>Peng</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>C.</given-names></name> <name><surname>Luo</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Safety and efficacy of a phage, kpssk3, in an <italic>in vivo</italic> model of Carbapenem-resistant Hypermucoviscous <italic>Klebsiella pneumoniae</italic> bacteremia</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>:<fpage>613356</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2021.613356</pub-id>, PMID: <pub-id pub-id-type="pmid">34093455</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silverberg</surname> <given-names>J. I.</given-names></name> <name><surname>Silverberg</surname> <given-names>N. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Epidemiology and extracutaneous comorbidities of severe acne in adolescence: a U.S. population-based study</article-title>. <source>Br. J. Dermatol.</source> <volume>170</volume>, <fpage>1136</fpage>&#x2013;<lpage>1142</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bjd.12912</pub-id>, PMID: <pub-id pub-id-type="pmid">24641612</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stothard</surname> <given-names>P.</given-names></name> <name><surname>Grant</surname> <given-names>J. R.</given-names></name> <name><surname>Van Domselaar</surname> <given-names>G.</given-names></name></person-group> (<year>2019</year>). <article-title>Visualizing and comparing circular genomes using the CGView family of tools</article-title>. <source>Brief. Bioinform.</source> <volume>20</volume>, <fpage>1576</fpage>&#x2013;<lpage>1582</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bib/bbx081</pub-id>, PMID: <pub-id pub-id-type="pmid">28968859</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>J. K.</given-names></name> <name><surname>Bhate</surname> <given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>A global perspective on the epidemiology of acne</article-title>. <source>Br. J. Dermatol.</source> <volume>172</volume>, <fpage>3</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bjd.13462</pub-id>, PMID: <pub-id pub-id-type="pmid">25597339</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toyne</surname> <given-names>H.</given-names></name> <name><surname>Webber</surname> <given-names>C.</given-names></name> <name><surname>Collignon</surname> <given-names>P.</given-names></name> <name><surname>Dwan</surname> <given-names>K.</given-names></name> <name><surname>Kljakovic</surname> <given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Propionibacterium acnes</italic> (<italic>P. acnes</italic>) resistance and antibiotic use in patients attending Australian general practice</article-title>. <source>Australas. J. Dermatol.</source> <volume>53</volume>, <fpage>106</fpage>&#x2013;<lpage>111</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1440-0960.2011.00867.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22571557</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Z.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Shi</surname> <given-names>Y.</given-names></name> <name><surname>Yin</surname> <given-names>S.</given-names></name> <name><surname>Shen</surname> <given-names>W.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2019a</year>). <article-title>Characterization and genome annotation of a newly detected bacteriophage infecting multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Arch. Virol.</source> <volume>164</volume>, <fpage>1527</fpage>&#x2013;<lpage>1533</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00705-019-04213-0</pub-id>, PMID: <pub-id pub-id-type="pmid">30900072</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Z.</given-names></name> <name><surname>Shi</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>C.</given-names></name> <name><surname>Luo</surname> <given-names>X.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Peng</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2019b</year>). <article-title>Lytic bacteriophage screening strategies for multidrug-resistant bloodstream infections in a burn intensive care unit</article-title>. <source>Med. Sci. Monit.</source> <volume>25</volume>, <fpage>8352</fpage>&#x2013;<lpage>8362</lpage>. doi: <pub-id pub-id-type="doi">10.12659/msm.917706</pub-id>, PMID: <pub-id pub-id-type="pmid">31693655</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Z.</given-names></name> <name><surname>Yin</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>G.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Huang</surname> <given-names>G.</given-names></name> <name><surname>Jiang</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2019c</year>). <article-title>Global transcriptomic analysis of the interactions between phage &#x03C6;Abp1 and extensively drug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>mSystems</source> <volume>4</volume>. doi: <pub-id pub-id-type="doi">10.1128/mSystems.00068-19</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>S.</given-names></name> <name><surname>Huang</surname> <given-names>G.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Jiang</surname> <given-names>B.</given-names></name> <name><surname>Yang</surname> <given-names>Z.</given-names></name> <name><surname>Dong</surname> <given-names>Z.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Phage Abp1 rescues human cells and mice from infection by pan-drug resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Cell. Physiol. Biochem.</source> <volume>44</volume>, <fpage>2337</fpage>&#x2013;<lpage>2345</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000486117</pub-id>, PMID: <pub-id pub-id-type="pmid">29258062</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zierdt</surname> <given-names>C. H.</given-names></name></person-group> (<year>1974</year>). <article-title>Properties of <italic>Corynebacterium acnes</italic> bacteriophage and description of an interference phenomenon</article-title>. <source>J. Virol.</source> <volume>14</volume>, <fpage>1268</fpage>&#x2013;<lpage>1273</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jvi.14.5.1268-1273.1974</pub-id>, PMID: <pub-id pub-id-type="pmid">4431080</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zierdt</surname> <given-names>C. H.</given-names></name> <name><surname>Webster</surname> <given-names>C.</given-names></name> <name><surname>Rude</surname> <given-names>W. S.</given-names></name></person-group> (<year>1968</year>). <article-title>Study of the anaerobic corynebacteria</article-title>. <source>Int. J. Syst. Evol. Microbiol.</source> <volume>18</volume>, <fpage>33</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1099/00207713-18-1-33</pub-id></citation></ref>
</ref-list>
<fn-group><fn id="fn0005"><p><sup>1</sup><ext-link xlink:href="http://www.ncbi.nlm.nih.gov/" ext-link-type="uri">http://www.ncbi.nlm.nih.gov/</ext-link></p></fn>
<fn id="fn0006"><p><sup>2</sup><ext-link xlink:href="http://www.bioinformatics.org/cgview/gallery.html" ext-link-type="uri">http://www.bioinformatics.org/cgview/gallery.html</ext-link></p></fn></fn-group>
</back>
</article>